Stroke epidemiology and stroke care services in India.
Jeyaraj Durai Pandian, Paulin Sudhan
https://pubmed.ncbi.nlm.nih.gov/24396806/Actively Recruiting
Led by Institute of medicine, Maharagjung medical campus · Updated on 2024-08-20
46
Participants Needed
2
Research Sites
65 weeks
Total Duration
Researchers are investigating how high blood sugar levels hyperglycemia affect short- and long-term outcomes in patients who come to the emergency department with acute strokes, also known as cerebrovascular accidents CVAs. This prospective cohort study aims to understand the connection between blood sugar levels at stroke onset and the rates of death and disability over one year. By studying this relationship, the research hopes to improve care and quality of life for stroke patients. The study will include 60 patients admitted to the emergency department with acute stroke, divided evenly between those with high blood sugar and those with normal levels. Researchers will use clinical assessments, blood glucose tests, and CT scans to confirm stroke diagnosis and severity. Participants will be followed up at 1 month, 3 months, and 12 months to monitor mortality and functional outcomes using tools like the Modified Rankin Score. The study uses a systematic random sampling method to select participants. During the year-long study, data will be gathered through chart reviews and face-to-face interviews at set intervals. Researchers will record vital signs, medical history, stroke type, and neurological scores, alongside blood glucose and imaging results. Statistical analyses will help identify factors linked to mortality and morbidity. This structured approach ensures accurate monitoring of patients health and helps clarify how hyperglycemia impacts stroke recovery and survival over time.
CONDITIONS
One Year Mortality and Morbidity With Hyperglycemia Among Acute Cerebrovascular Accident Patients in Emergency Department: A Cohort Study
B
Bibek Rajbhandari, masters
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Institute of medicine, Maharagjung medical campus
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Within 24 hours of symptom onset
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 day
Participants undergo diagnostic tests including blood glucose measurement and CT imaging to confirm acute stroke and assess stroke severity.
1 visit (in-person)
Duration - 1 year
Participants are followed to assess mortality and morbidity outcomes at multiple time points after the stroke event.
Face-to-face interviews at 1 month, 3 months, and 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jeyaraj Durai Pandian, Paulin Sudhan
https://pubmed.ncbi.nlm.nih.gov/24396806/M Patrice Lindsay, Bo Norrving, Ralph L Sacco...
https://pubmed.ncbi.nlm.nih.gov/31658892/Marija Bender, Edin Jusufovic, Vesna Railic...
https://pubmed.ncbi.nlm.nih.gov/29284999/Valery L Feigin, Carlene M M Lawes, Derrick A Bennett...
https://pubmed.ncbi.nlm.nih.gov/19233729/Javier Mar, Jaime Masjuan, Juan Oliva-Moreno...
https://pubmed.ncbi.nlm.nih.gov/25889480/Jacob Liljehult, Thomas Christensen, Karl Bang Christensen
https://pubmed.ncbi.nlm.nih.gov/32044222/Eric S Donkor
https://pubmed.ncbi.nlm.nih.gov/30598741/Barbara E Bates, Dawei Xie, Pui L Kwong...
https://pubmed.ncbi.nlm.nih.gov/24211696/Alessandra C Goulart, Isabela M Bensenor, Tiotrefis G Fernandes...
https://pubmed.ncbi.nlm.nih.gov/21705233/GBD 2016 Stroke Collaborators
https://pubmed.ncbi.nlm.nih.gov/30871944/Institute of medicine, Maharagjung medical campus
Lead Sponsor